title: [A study of 5-ASA use among young patients with Crohn disease. Regular drug revision is of significance for all children with chronic disease].
authors.affiliation: Apoteket Danderyds sjukhus, Stockholm. annika.hedin@apoteket.se
authors.forename: A
authors.initials: A
authors.lastname: Hedin
authors.forename: H
authors.initials: H
authors.lastname: Ehrsson
authors.forename: S
authors.initials: S
authors.lastname: Eksborg
authors.forename: Y
authors.initials: Y
authors.lastname: Finkel
authors.forename: H
authors.initials: H
authors.lastname: Hildebrand
authors.forename: A K
authors.initials: AK
authors.lastname: Lidehäll
mesh_terms: D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001835:Body Weight; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D019804:Mesalamine / Q000008:administration & dosage*; D012189:Retrospective Studies; D012460:Sulfasalazine / Q000008:administration & dosage*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine; D019804:Mesalamine